| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $208.8M | -18.0% |
| R&D Expense | $11.8M | -31.5% |
| SG&A Expense | $34.7M | -7.9% |
| Operating Income | -$20.3M | +14.1% |
| Interest Expense | $3.1M | -35.3% |
| Pre-tax Income | -$27.2M | +12.6% |
| Income Tax | -$2K | +99.9% |
| Net Income | -$27.2M | +7.2% |
| EPS (Basic) | -$1.05 | +41.7% |
| EPS (Diluted) | -$1.05 | +41.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $12.9M | +37.0% |
| Accounts Receivable | $28.5M | -38.8% |
| Current Assets | $67.5M | +2.3% |
| Total Assets | $89.1M | -4.8% |
| Current Liabilities | $65.0M | +0.5% |
| Long-term Debt | $34.6M | -2.8% |
| Total Liabilities | $70.9M | +3.3% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.5M | +89.6% |
| Capital Expenditures | $69K | +430.8% |
| Investing Cash Flow | -$6.4M | -2.5% |
| Financing Cash Flow | $10.8M | -29.1% |
| Free Cash Flow | -$1.5M | +89.1% |
| $18.2M |
| -27.0% |